Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Simonneau, N. Galiè, M.M. Hoeper, A. Kusic-Pajic, J.C. Lemarié, L.J. Rubin (Le Kremlin Bicêtre, Paris, France; Bologna, Italy; Hanover, Germany; Allschwil, Switzerland; San Diego, United States Of America). Prognostic risk factors of disease worsening in patients with functional class II pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 1508

Member's Comments

No comment yet.

Related content which might interest you: Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Predictive factors of clinical worsening in functional class II patients with pulmonary arterial hypertension (PAH) in the EARLY trial of bosentan Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Impact of functional class change on survival in patients with pulmonary arterial hypertension in the REVEAL registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Prognostic factors in surgically-treated chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 The prevalence of pulmonary hypertension and the related factors in hemodialysis patients Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Predictor markers of early pulmonary hypertension in patients with collagen diseases Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Prognostic factors in non-surgical chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018